Imidazopyridine-Based Fatty Acid Synthase Inhibitors That Show Anti-HCV Activity and in Vivo Target Modulation

ACS Med Chem Lett. 2012 Dec 2;4(1):113-7. doi: 10.1021/ml300335r. eCollection 2013 Jan 10.


Potent imidazopyridine-based inhibitors of fatty acid synthase (FASN) are described. The compounds are shown to have antiviral (HCV replicon) activities that track with their biochemical activities. The most potent analogue (compound 19) also inhibits rat FASN and inhibits de novo palmitate synthesis in vitro (cell-based) as well as in vivo.

Keywords: FASN; HCV; antiviral; in vivo; inhibitor; reversible; structure−activity relationship; target modulation.